Table 1 Base-case values and ranges (95% confidence intervals)
Variable | Mean (range) | Reference |
|---|---|---|
Absolute reduction of remission rate (%) | 9.9 (2.7–17.2) | [12] |
Preference score | [16] | |
- Remission of depression | 0.73 (0.69–0.77) | |
- Moderate depression | 0.51 (0.47–0.55) | |
- Severe depression | 0.37 (0.33–0.41) | |
Cost per CBT session (€) | 103.87 | [5] |
Cost of 100 mg fluvoxamine over 12 months considering mandatory rebates for the SHI (€) | 70.96 | [19] |
Direct costs of depression over two months excluding costs of psychotherapy (€) | 173.30 | [17] |
Indirect costs (€) | 0 (200.64) | [17] |
Number of CBT sessions | 15 | [14] |
Proportion of patients with moderate depression (%) | 68 (61–75) | [18] |
Proportion of depressive patients receiving psychotherapy (%) | 10 (6–15) | [18] |
Proportion of depressive patients receiving antidepressants (%) | 26 (19–33) | [18] |